Nisa Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-122,131
Closed -$14.1M 2817
2023
Q3
$14.1M Buy
122,131
+99,908
+450% +$10.7M 0.11% 206
2023
Q2
$2.29M Buy
22,223
+7,177
+48% +$757K 0.02% 646
2023
Q1
$1.64M Sell
15,046
-35,294
-70% -$3.9M 0.01% 716
2022
Q4
$5.73M Buy
50,340
+49,400
+5,255% +$4.1M 0.05% 390
2022
Q3
$60K Sell
940
-21,772
-96% -$1.52M ﹤0.01% 1682
2022
Q2
$1.81M Buy
22,712
+200
+0.9% +$18.9K 0.02% 664
2022
Q1
$2.37M Sell
22,512
-5,236
-19% -$510K 0.02% 627
2021
Q4
$2.59M Sell
27,748
-7,961
-22% -$868K 0.02% 576
2021
Q3
$3.91K Sell
35,709
-6,442
-15% -$669K 0.02% 515
2021
Q2
$3.95K Hold
42,151
0.02% 524
2021
Q1
$3.88K Buy
42,151
+28,100
+200% +$2.37M 0.02% 516
2020
Q4
$1.03M Buy
14,051
+5,197
+59% +$386K 0.01% 916
2020
Q3
$688K Sell
8,854
-26,139
-75% -$1.8M 0.01% 939
2020
Q2
$1.95M Buy
34,993
+13,933
+66% +$596K 0.02% 588
2020
Q1
$624K Hold
21,060
0.01% 858
2019
Q4
$762K Buy
21,060
+300
+1% +$9.2K 0.01% 971
2019
Q3
$565K Sell
20,760
-13,774
-40% -$356K 0.01% 1055
2019
Q2
$831K Hold
34,534
0.01% 910
2019
Q1
$913K Buy
34,534
+12,539
+57% +$297K 0.01% 868
2018
Q4
$430K Hold
21,995
﹤0.01% 1041
2018
Q3
$431K Buy
21,995
+21,270
+2,934% +$404K ﹤0.01% 1145
2018
Q2
$12K Hold
725
﹤0.01% 1695
2018
Q1
$10K Buy
+725
New +$10.7K ﹤0.01% 1673
2017
Q2
Sell
-5,000
Closed -$74K 1882
2017
Q1
$74K Hold
5,000
﹤0.01% 1398
2016
Q4
$81K Buy
+5,000
New +$90.7K ﹤0.01% 1375

Other funds holding HZNP

Nisa Investment Advisors's HZNP Position: Q4 2023 in Review

Nisa Investment Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 122,131 shares — an estimated $14.1M sold.

Nisa Investment Advisors first reported a position in HZNP in Q4 2016 and held it in 25 quarters. The position peaked at $14.1M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Nisa Investment Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 122,131 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $14.1M.
  • Nisa Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 25 quarters.
  • Nisa Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $14.1M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.